10X Genomics is off to a hot start as a publicly traded company. The life sciences firm, which provides scientists gene sequencing technologies to help cure chronic diseases like cancer and Alzheimer's, soared in its debut Thursday. Serge Saxonov, Founder and CEO of 10x Genomics, joined Cheddar to discuss what's behind the early demand from investors.